US FDA gives more time to suggest improvements to 510(k) process
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has extended to 19 March the period for stakeholders to submit feedback on agency’s proposal to improve its 510(k) premarket notification process for medical devices1. The original comment period expires today2.